TOI
Oncology Institute Inc
6.20$
+20.9%
vs. previous close
Closing price · As of: Aug 11, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.2% | 80.5% | 83.2% | 87.4% | 86.8% | 85.6% | 85.4% | 83.5% | 85.4% | 86.1% | 84.0% | 85.3% | 85.2% | |
| 18.8% | 19.5% | 16.8% | 12.6% | 13.2% | 14.4% | 14.6% | 16.5% | 14.6% | 13.9% | 16.0% | 14.7% | 14.8% | |
| 35.8% | 34.4% | 32.7% | 30.1% | 28.3% | 26.7% | 24.8% | 24.3% | 22.5% | 18.5% | 19.8% | 19.1% | 19.9% | |
| 37.5% | 36.5% | 34.6% | 31.6% | 29.8% | 28.2% | 26.5% | 26.0% | 24.0% | 19.8% | 20.9% | 19.1% | 20.8% | |
| -18.6% | -17.0% | -17.8% | -19.0% | -16.6% | -13.9% | -11.9% | -9.5% | -9.4% | -5.9% | -4.9% | -4.4% | -6.0% | |
| 3.3% | 3.3% | 2.3% | 2.1% | 2.1% | 2.2% | 1.2% | 5.3% | 1.6% | 1.4% | 1.3% | 1.3% | 1.4% | |
| -20.9% | -21.1% | -22.2% | -21.0% | -15.7% | -16.1% | -13.1% | -18.8% | -14.3% | -12.1% | -5.3% | -1.7% | -8.0% | |
| 0.1% | 0.2% | -0.4% | -0.3% | -2.8% | – | 3.6% | – | -0.1% | – | – | – | – | |
| -21.1% | -21.2% | -21.9% | -21.0% | -15.7% | -16.1% | -13.1% | -18.8% | -14.2% | -12.1% | -5.3% | -1.7% | -8.0% | |
| -16.9% | -14.9% | -16.1% | -17.3% | -12.0% | -12.3% | -10.3% | -11.7% | -11.2% | -9.4% | -2.8% | 0.7% | -5.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.